Sundar.M
☆    

India,
2019-02-15 13:37
(584 d 02:49 ago)

Posting: # 19925
Views: 914
 

 Dose curve [PK / PD]

Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN
Activity
 Admin contact
21,068 posts in 4,392 threads, 1,466 registered users;
online 21 (2 registered, 19 guests [including 5 identified bots]).
Forum time: Monday 17:27 CEST (Europe/Vienna)

I have finally come to the konklusion
that a good reliable set ov bowels
iz worth more to a man
than enny quantity of brains.    Josh Billings

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5